# RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

> **NCT07674147** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Autoimmune Diseases
- SLE - Systemic Lupus Erythematosus
- SSc-Systemic Sclerosis
- IIM- Idiopathic Inflammatory Myopathies
- IgAN - IgA Nephropathy
- Multi-Drug Resistant Nephrotic Syndrome

## Interventions

- **DRUG:** RD06-05 CART Cell Infusion

## Key facts

- **NCT ID:** NCT07674147
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2029-07
- **Final completion:** 2030-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674147, "RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*